Allscripts’ Earnings Report Shows Continued Slump | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Allscripts’ Earnings Report Shows Continued Slump

May 10, 2013
by Gabriel Perna
| Reprints

Chicago-based electronic health record (EHR) software provider, Allscripts continues to find itself in a slump, according to the results of its first full quarter earnings report since the company made significant leadership changes.

The company, which had a notable quarter for its high-profile acquisitions of dbMotion and Jardogs, reported that its bookings of $177.7 million were down from $194.6 million in the first quarter of 2012 and $180.7 million in the fourth quarter of 2012. Overall revenue was down from of $364.7 million a year ago to $347.1 million this past quarter. The company posted an operating loss of $28.3 million in the first quarter, compared with an operating income of $13.0 million in the first quarter of 2012. 

The past year has been an interesting one for Allscripts as dealt with the removal of former CEO Glen Tullman and subsequent appointment of former Cerner COO Paul Black. It’s also dealt with its share of legal battles and rumors of it being bought out by a private equity firm.

News of the company’s earnings has dropped its stock price from $13.85 per share at the end of day yesterday to $13.28 per share (press time).

"We are making progress in key areas including an unwavering client focus, delivering on our commitments and driving operational effectiveness," Paul M. Black, president CEO of Allscripts, said in a statement. “We are investing heavily in both our clients and our products and so while our financial results for the quarter are not surprising, they are not satisfactory and not indicative of our long term potential. This is a rebuilding year for Allscripts and I remain confident we are taking the right steps forward."

The complete report can be found here.

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

KLAS Research: Small Hospitals’ Buying Decisions Impacting EMR Market Share

A new KLAS Research report tracks shifts in electronic medical record (EMR) vendor market share among acute care hospitals, and finds that smaller hospitals are seeking technology solutions that meet their needs and limited budgets, and these contracts are making a mark on the EMR market.

Survey: Majority of Providers Predict Success for New Generic Drug Company, Project Rx

Back in January, four health systems, in consultation with the VA, announced a collaboration to develop a new, not-for-profit generic drug company. A survey has found that 90 percent of providers say they would become customers of the new venture.

Personalized Medicine Awareness Low Among U.S. Adults, Survey Finds

Genetics and personalized medicine are not top of mind for the general public in the U.S., according to a recent survey from GenomeWeb and the Personalized Medicine Coalition.

Industry Organizations Praise Senate Passage of VA Mission Act

The U.S. Senate on Wednesday passed, by a vote of 92-5, a major Veterans Affairs (VA) reform bill that includes health IT-related provisions to improve health data exchange between VA healthcare providers and community care providers.

NIH Issues Funding Announcement for All of Us Genomic Research Program

The National Institutes of Health’s (NIH) “All of Us” Research Program has issued a funding announcement for genome centers to generate genotype and whole genome sequence data from participants’ biosamples.

MGMA: Physician Compensation Data Illustrates Nationwide PCP Shortage

Primary care physicians’ compensation rose by more than 10 percent over the past five years, representing an increase which is nearly double that of specialty physicians’ compensation over the same period, according to the Medical Group Management Association (MGMA).